CONDENSED CONSOLIDATED STATEMENTS OF STOCKHOLDERS’ EQUITY (UNAUDITED) - USD ($) $ in Thousands	Total	Common Stock	Additional Paid-In Capital	Accumulated Other Comprehensive Loss	Retained Earnings
Balance at beginning of period (in shares) at Dec. 31, 2024		102,199,000
Balance at beginning of period at Dec. 31, 2024	$ 1,378,003	$ 102	$ 1,418,150	$ (65,138)	$ 24,889
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	17,350				17,350
Other comprehensive income (loss)	11,472			11,472
Dividends declared	(60,163)		(60,163)
Net issuances of restricted stock (in shares)		823,000
Net issuances of restricted stock	0	$ 1	(1)
Stock-based compensation	16,705		16,705
Repurchases of common stock (in shares)		(858,000)
Repurchases of common stock	(50,145)	$ (1)	(7,905)		(42,239)
Balance at ending of period (in shares) at Mar. 31, 2025		102,164,000
Balance at end of period at Mar. 31, 2025	1,313,222	$ 102	1,366,786	(53,666)	0
Balance at beginning of period (in shares) at Dec. 31, 2024		102,199,000
Balance at beginning of period at Dec. 31, 2024	1,378,003	$ 102	1,418,150	(65,138)	24,889
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	58,318
Other comprehensive income (loss)	35,111
Balance at ending of period (in shares) at Jun. 30, 2025		101,739,000
Balance at end of period at Jun. 30, 2025	1,311,918	$ 102	1,341,843	(30,027)	0
Balance at beginning of period (in shares) at Mar. 31, 2025		102,164,000
Balance at beginning of period at Mar. 31, 2025	1,313,222	$ 102	1,366,786	(53,666)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	40,968				40,968
Other comprehensive income (loss)	23,639			23,639
Dividends declared	(60,284)		(39,473)		(20,811)
Net issuances of restricted stock (in shares)		36,000
Stock-based compensation	14,530		14,530
Repurchases of common stock (in shares)		(461,000)
Repurchases of common stock	(20,157)	$ 0			(20,157)
Balance at ending of period (in shares) at Jun. 30, 2025		101,739,000
Balance at end of period at Jun. 30, 2025	$ 1,311,918	$ 102	1,341,843	(30,027)	0
Balance at beginning of period (in shares) at Dec. 31, 2025	101,140,684	101,141,000
Balance at beginning of period at Dec. 31, 2025	$ 1,275,857	$ 101	1,304,939	(29,183)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	13,790				13,790
Other comprehensive income (loss)	(4,018)			(4,018)
Dividends declared	(59,647)		(51,867)		(7,780)
Net issuances of restricted stock (in shares)		1,402,000
Net issuances of restricted stock	0	$ 1	(1)
Stock-based compensation	11,259		11,259
Repurchases of common stock (in shares)		(249,000)
Repurchases of common stock	(6,010)				(6,010)
Balance at ending of period (in shares) at Mar. 31, 2026		102,294,000
Balance at end of period at Mar. 31, 2026	$ 1,231,231	$ 102	1,264,330	(33,201)	0
Balance at beginning of period (in shares) at Dec. 31, 2025	101,140,684	101,141,000
Balance at beginning of period at Dec. 31, 2025	$ 1,275,857	$ 101	1,304,939	(29,183)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	40,108
Other comprehensive income (loss)	$ (5,970)
Balance at ending of period (in shares) at Jun. 30, 2026	102,361,829	102,362,000
Balance at end of period at Jun. 30, 2026	$ 1,207,659	$ 102	1,242,710	(35,153)	0
Balance at beginning of period (in shares) at Mar. 31, 2026		102,294,000
Balance at beginning of period at Mar. 31, 2026	1,231,231	$ 102	1,264,330	(33,201)	0
Increase (Decrease) in Stockholders' Equity [Roll Forward]
Net income	26,318				26,318
Other comprehensive income (loss)	(1,952)			(1,952)
Dividends declared	(60,346)		(34,158)		(26,188)
Net issuances of restricted stock (in shares)		69,000
Stock-based compensation	12,538		12,538
Repurchases of common stock (in shares)		(1,000)
Repurchases of common stock	$ (130)				(130)
Balance at ending of period (in shares) at Jun. 30, 2026	102,361,829	102,362,000
Balance at end of period at Jun. 30, 2026	$ 1,207,659	$ 102	$ 1,242,710	$ (35,153)	$ 0